Optieum Biotechnologies Inc.
Optieum Biotechnologies, Inc. Alias
CAR-T Therapy Manufacturing
cGMP Biopharmaceutical Production
Cell Therapy Development
Allogenic NK cell therapies
CAR-T cell therapies
CAR-NK therapies
scFv generation platform (Eumbody System)
Biotechnology platform for functional scFvs
Discovery and development of CAR‑T cell therapies
Manufacturing of CAR‑T therapies (cGMP)
Development of proprietary Eumbody System
CAR-T cell therapy discovery and development
lentiviral vector development
gene therapy vector manufacturing
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
GI CELL
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Japanese Agency for Medical Research and Development
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Bank

+ Loaded when opened
2026-09-21 18:14 (Model: ggml-org/gpt-oss-20b )
↑